These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38114843)
1. Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation. Huang J; Huang S; Liu S; Feng L; Huang W; Wang Y; Huang D; Huang T; Huang X AAPS PharmSciTech; 2023 Dec; 25(1):4. PubMed ID: 38114843 [TBL] [Abstract][Full Text] [Related]
2. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation. Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189 [TBL] [Abstract][Full Text] [Related]
3. Enhanced Intramuscular Bioavailability of Cannabidiol Using Nanocrystals: Formulation, In Vitro Appraisal, and Pharmacokinetics. Fu X; Xu S; Li Z; Chen K; Fan H; Wang Y; Xie Z; Kou L; Zhang S AAPS PharmSciTech; 2022 Mar; 23(3):85. PubMed ID: 35288801 [TBL] [Abstract][Full Text] [Related]
4. Controlled preparation of curcumin nanocrystals by detachable stainless steel microfluidic chip. Zheng X; Zhang J; Zhang L; Huangfu X; Li Y; Chen J Int J Pharm; 2024 Sep; 663():124574. PubMed ID: 39134290 [TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation. Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446 [TBL] [Abstract][Full Text] [Related]
6. Novel breviscapine nanocrystals modified by panax notoginseng saponins for enhancing bioavailability and synergistic anti-platelet aggregation effect. Jin X; Luo Y; Chen Y; Ma Y; Yue P; Yang M Colloids Surf B Biointerfaces; 2019 Mar; 175():333-342. PubMed ID: 30554011 [TBL] [Abstract][Full Text] [Related]
7. The potential of intranasal delivery of nanocrystals in powder form on the improvement of zaleplon performance: Latif R; Makar RR; Hosni EA; El Gazayerly ON Drug Dev Ind Pharm; 2021 Feb; 47(2):268-279. PubMed ID: 33501862 [TBL] [Abstract][Full Text] [Related]
8. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Jain S; Reddy VA; Arora S; Patel K Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488 [TBL] [Abstract][Full Text] [Related]
9. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Ahmad M; Khan S; Shah SMH; Zahoor M; Hussain Z; Hussain H; Shah SWA; Ullah R; Alotaibi A Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189682 [TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs. Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438 [TBL] [Abstract][Full Text] [Related]
11. Quercetin nanocrystals prepared using a microfluidic chip with improved in vitro dissolution. Zheng G; Wu W; Liu Z; Lv Y; Luo Y; Che X; Wang L Pharm Dev Technol; 2024 Mar; 29(3):143-152. PubMed ID: 38353125 [TBL] [Abstract][Full Text] [Related]
12. Appraisal of Felodipine Nanocrystals for Solubility Enhancement and Pharmacodynamic Parameters on Cadmium Chloride Induced Hypertension in Rats. Maurya P; Pandey P; Singh S; Sonkar A; Singh S; Saraf SA Curr Drug Deliv; 2022; 19(5):625-634. PubMed ID: 34325637 [TBL] [Abstract][Full Text] [Related]
13. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation. Shen B; Wu N; Shen C; Zhang F; Wu Y; Xu P; Zhang L; Wu W; Lu Y; Han J; Wang Y; Yuan H Drug Dev Ind Pharm; 2016 Nov; 42(11):1772-81. PubMed ID: 27032257 [TBL] [Abstract][Full Text] [Related]
14. A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies. Narayan R; Pednekar A; Bhuyan D; Gowda C; Koteshwara KB; Nayak UY Int J Nanomedicine; 2017; 12():4921-4935. PubMed ID: 28744125 [TBL] [Abstract][Full Text] [Related]
15. Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study. Liu C; Lv L; Guo W; Mo L; Huang Y; Li G; Huang X Biomed Res Int; 2018; 2018():6763057. PubMed ID: 30363745 [TBL] [Abstract][Full Text] [Related]
16. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980 [TBL] [Abstract][Full Text] [Related]
17. Oral fast-dissolving films containing lutein nanocrystals for improved bioavailability: formulation development, in vitro and in vivo evaluation. Liu C; Chang D; Zhang X; Sui H; Kong Y; Zhu R; Wang W AAPS PharmSciTech; 2017 Nov; 18(8):2957-2964. PubMed ID: 28462465 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes. Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865 [TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. Li J; Guo X; Liu Z; Okeke CI; Li N; Zhao H; Aggrey MO; Pan W; Wu T Drug Dev Ind Pharm; 2014 Jul; 40(7):980-7. PubMed ID: 23662696 [TBL] [Abstract][Full Text] [Related]
20. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Ige PP; Baria RK; Gattani SG Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]